OpenAI has introduced Genebench-Pro, a new benchmark designed to rigorously test AI models on complex genomics problems. Unveiled on June 30, 2026, this benchmark features 10 detailed case studies, each replicating real-world challenges in genetic and clinical research.
These case studies span critical areas, including structural variant-guided tumor therapy, CRISPR target validation, and Mendelian randomization for drug target prioritization. Each scenario provides a specific prompt, relevant datasets, and supporting materials, requiring AI models to produce precise JSON-formatted answers and analytical reasoning.